☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Fast track
Dermira‘s Lebrikizumab Receives the US FDA's Fast Track Designation to Treat Atopic Dermatitis
December 11, 2019
Boehringer Ingelheim and Eli Lilly's Empagliflozin Receive FDA's Fast Track Designation for Chronic Heart Failure
June 26, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.